Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Non-cash Items (2016 - 2025)

CorMedix's Non-cash Items history spans 11 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 90.24% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, down 90.24%, while the annual FY2025 figure was $2.3 million, 90.24% down from the prior year.
  • Non-cash Items for Q4 2025 was $2.3 million at CorMedix, down from $3.3 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $23.6 million in Q4 2024 and bottomed at $337075.0 in Q4 2021.
  • The 5-year median for Non-cash Items is $7.0 million (2023), against an average of $6.4 million.
  • The largest annual shift saw Non-cash Items soared 230.21% in 2022 before it tumbled 94.2% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $337075.0 in 2021, then skyrocketed by 230.21% to $1.1 million in 2022, then soared by 483.98% to $6.5 million in 2023, then skyrocketed by 262.58% to $23.6 million in 2024, then tumbled by 90.24% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Non-cash Items are $2.3 million (Q4 2025), $3.3 million (Q3 2025), and $2.4 million (Q2 2025).